{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:29:24Z","timestamp":1790335764656,"version":"4.1.0"},"reference-count":31,"publisher":"Japanese Pharmacological Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pharmacol Sci"],"published-print":{"date-parts":[[2010]]},"DOI":"10.1254\/jphs.09283fp","type":"journal-article","created":{"date-parts":[[2010,2,18]],"date-time":"2010-02-18T06:03:11Z","timestamp":1266472991000},"page":"184-191","source":"Crossref","is-referenced-by-count":23,"title":["Demonstration of Direct Neurite\u2013Osteoclastic Cell Communication In Vitro via the Adrenergic Receptor"],"prefix":"10.1254","volume":"112","author":[{"given":"Satoko","family":"Suga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigemi","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akifumi","family":"Togari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"332","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(97)00649-6"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(00)02700-1"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1002\/jemt.10121"},{"issue":"1\/3","key":"4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0014-5793(04)00053-5","volume":"559","author":"SPENCER G J","year":"2004","ISSN":"https:\/\/id.crossref.org\/issn\/0014-5793","issn-type":"print"},{"key":"5","unstructured":"5 Chenu C. Role of innervation in the control of bone remodeling. J Musculoskelet Neuronal Interact. 2004;4:132–134."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Togari A, Arai M, Kondo A. The role of the sympathetic nervous system in controlling bone metabolism. Expert Opin Ther Targets. 2005;9:931–940.","DOI":"10.1517\/14728222.9.5.931"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.FM0070227"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Opp MR, Imeri L. Sleep as a behavioral model of neuro-immune interactions. Acta Neurobiol Exp. 1999;59:45–53.","DOI":"10.55782\/ane-1999-1295"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1054\/mehy.2001.1408"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Chesnokova V, Melmed S. Neuro-immuno-endocrine modulation of the hypothalamic-pituitary-adrenal (HPA) axis by gp130 signaling molecules. Endocrinology. 2002;143:1571–1574.","DOI":"10.1210\/endo.143.5.8861"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Bjurholm A, Kreicbergs A, Terenius L, Goldstein M, Schultzberg M. Neuropeptide Y-, tyrosine hydroxylase- and vasoactive intestinal polypeptide-immunoreactive nerves in bone and surrounding tissues. J Auton Nerv Syst. 1988;25:119–125.","DOI":"10.1016\/0165-1838(88)90016-1"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Hill EL, Elde R. Distribution of CGRP-, VIP-, Dβ<\/I>H-, SP-, and NPY-immunoreaetive nerves in the periosteum of the rat. Cell Tissue Res. 1991;264:469–480.","DOI":"10.1007\/BF00319037"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.84.9.2975"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Stead RH, Bienenstock J. Cellular interactions between the immune and peripheral nervous systems: a normal role for mast cells? In: Burger MM, Sordat B, Zinkernagel RM, editors. Cell to cell interaction. Basel: Karger; 1990. p. 170–187.","DOI":"10.1159\/000419807"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 McKay DM, Bienenstock J. The interaction between mast cells and nerves in the gastrointestinal tract. Immunol Today. 1994;15:533–538.","DOI":"10.1016\/0167-5699(94)90210-0"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Suzuki R, Furuno T, Mckay DM, Wolvers D, Teshima R, Nakanishi M, et al. Direct neurite-mast cell communication in vitro occurs via the neuropeptide substance P. J Immunol. 1999;163:2410–2415.","DOI":"10.4049\/jimmunol.163.5.2410"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2004.08.008"},{"issue":"30","key":"18","doi-asserted-by":"crossref","first-page":"5917","DOI":"10.1016\/j.febslet.2007.11.065","volume":"581","author":"OBATA KOJI","year":"2007","ISSN":"https:\/\/id.crossref.org\/issn\/0014-5793","issn-type":"print"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(02)01049-8"},{"issue":"2\/3","key":"20","first-page":"137","volume":"1640","author":"ARAI M","year":"2003","ISSN":"https:\/\/id.crossref.org\/issn\/0005-2728","issn-type":"print"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(90)90165-6"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1007\/BF00318146"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Janiszewski J, Bienenstock J, Blennerhassett MG. Picomolar doses of substance P trigger electrical responses in mast cells without degranulation. Am J Physiol. 1994;267:C138–C145.","DOI":"10.1152\/ajpcell.1994.267.1.C138"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Mori N, Suzuki R, Furuno T, McKay DM, Wada M, Teshima R, et al. Nerve-mast cell (RBL) interaction: RBL membrane ruffling occurs at the contact site with an activated neurite. Am J Physiol. 2002;283:C1738–C1744.","DOI":"10.1152\/ajpcell.00050.2002"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.27.1891"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M607999200"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Duplomb L, Baud’huin M, Charrier C, Berreur M, Trichet V, Blanchard F, et al. Interleukin-6 inhibits receptor activator of nuclear factor κ<\/I>B ligand-induced osteoclastogenesis by diverting cells into the macrophage linage: key role of serine727 <\/SUP>phosphorylation of signal transducer and activator of transcription 3. Endocrinol. 2008;149:3688–3697.","DOI":"10.1210\/en.2007-1719"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Axmann R, Bohm C, Kronke G, Zwerina J, Smolen J, Schett G. Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo. Arthritis Rheum. 2009;60:2747–2756.","DOI":"10.1002\/art.24781"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Lundberg P, Lie A, Bjurholm B, Lehenkari PP, Lerner UH, Ransjo M, et al. Vasoactive intestinal peptide regulates osteoclast activity via specific binding site on both osteoblasts and osteoclasts. Bone. 2000;27:803–810.","DOI":"10.1016\/S8756-3282(00)00394-X"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1999.1220"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Perez DM, Papay RS, Shi T. α<\/I>1-Adrenergic receptor stimulates interleukin-6 expression and secretion through both mRNA stability and transcriptional regulation: involvement of p38 mitogen-activated protein kinase and nuclear factor-κ<\/I>B. Mol Pharmacol. 2009;76:144–152.","DOI":"10.1124\/mol.108.054320"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,3,24]],"date-time":"2024-03-24T03:37:46Z","timestamp":1711251466000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jphs\/112\/2\/112_09283FP\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1254\/jphs.09283fp","relation":{},"ISSN":["1347-8613","1347-8648"],"issn-type":[{"value":"1347-8613","type":"print"},{"value":"1347-8648","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010]]}}}